Treatment With Combination of Lenalidomide and Rituximab Achieves Durable Responses in a Long Term Follow Up of Patients With Indolent Non-Hodgkin's Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.2438_79
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

A Phase Ii Trial of Rituximab/Lenalidomide Followed by Lenalidomide Maintenance in Untreated and Relapsed Indolent Lymphoma: Long Term Follow Up and Correlative Analysis

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Characteristics and Management of Rash Following Lenalidomide and Rituximab in Patients With Untreated Indolent Non-Hodgkin Lymphoma

Haematologica
Hematology
2015English

A Phase II Study of Bendamustine in Combination With Rituximab as Initial Treatment for Patients With Indolent Non-Follicular Non-Hodgkin Lymphoma

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2016English

Long-Term Follow-Up of Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma Receiving Purged Autografts After Induction Failure

Bone Marrow Transplantation
TransplantationHematology
2009English

Long-Term Follow-Up After Localized Radiotherapy in Patients With Transformed B-Cell Lymphoma Treated With Rituximab-Containing Chemotherapy

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine

Hepatology
MedicineHepatology
2018English

Clinical Stage 1 Non-Hodgkin's Lymphoma: Long-Term Follow-Up of Patients Treated by the British National Lymphoma Investigation With Radiotherapy Alone as Initial Therapy

British Journal of Cancer
Cancer ResearchOncology
1994English

A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma

British Journal of Haematology
Hematology
2015English

A Long-Term Follow-Up of 33 Patients With Non-Hodgkin's Lymphoma Who Received the BEAM High-Dose Intensification Regimen With Cytokine Support Only and No Transplant

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy